Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 29, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-07-21
DOI
10.1126/sciadv.abo3610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1
- (2022) Neeraj Singh et al. Science Advances
- BACE1 controls synaptic function through modulating release of synaptic vesicles
- (2021) Brati Das et al. MOLECULAR PSYCHIATRY
- Amyloid β-protein and beyond: the path forward in Alzheimer’s disease
- (2020) Dominic M Walsh et al. CURRENT OPINION IN NEUROBIOLOGY
- Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
- (2020) Gerald Novak et al. Alzheimers Research & Therapy
- β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification
- (2020) Harald Hampel et al. Alzheimers Research & Therapy
- The two faces of synaptic failure in AppNL-G-F knock-in mice
- (2020) Amira Latif-Hernandez et al. Alzheimers Research & Therapy
- BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer’s disease brain
- (2020) Cyrille Sur et al. BRAIN
- Alzheimer disease risk genes: 29 and counting
- (2019) Lars Bertram et al. Nature Reviews Neurology
- A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment
- (2019) Brati Das et al. CNS DRUGS
- Lack of β-amyloid cleaving enzyme-1 (BACE1) impairs long-term synaptic plasticity but enhances granule cell excitability and oscillatory activity in the dentate gyrus in vivo
- (2019) Matej Vnencak et al. Brain Structure & Function
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease
- (2019) Sung Hoon Baik et al. Cell Metabolism
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- Investigational BACE inhibitors for the treatment of Alzheimer’s disease
- (2019) Bruno P. Imbimbo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
- (2019) Alette M. Wessels et al. JAMA Neurology
- BACE1 partial deletion induces synaptic plasticity deficit in adult mice
- (2019) Sylvia Lombardo et al. Scientific Reports
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function
- (2018) Kaichuan Zhu et al. BIOLOGICAL PSYCHIATRY
- High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease
- (2018) Dunja Mrdjen et al. IMMUNITY
- BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
- (2018) Xiangyou Hu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Microglia-Mediated Synapse Loss in Alzheimer's Disease
- (2018) Lawrence Rajendran et al. JOURNAL OF NEUROSCIENCE
- Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
- (2018) Dannielle DeWaal et al. Nature Communications
- Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice
- (2018) Ming-Hsuan Ou-Yang et al. Science Translational Medicine
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
- (2017) Rebecca Sims et al. NATURE GENETICS
- Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution
- (2017) Hansruedi Mathys et al. Cell Reports
- Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease
- (2016) Claudio Villegas-Llerena et al. CURRENT OPINION IN NEUROBIOLOGY
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Label-free Quantitative Proteomics of Mouse Cerebrospinal Fluid Detects β-Site APP Cleaving Enzyme (BACE1) Protease Substrates In Vivo
- (2015) Bastian Dislich et al. MOLECULAR & CELLULAR PROTEOMICS
- High-throughput functional genomics using CRISPR–Cas9
- (2015) Ophir Shalem et al. NATURE REVIEWS GENETICS
- Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer
- (2015) Oncotarget
- The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
- (2013) Patty C. Kandalepas et al. ACTA NEUROPATHOLOGICA
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus
- (2008) H. Wang et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search